Proteus Digital Health’s ingestible sensor, an adherence tool that’s been successfully tested before in patients with diabetes and heart failure, also has utility for those on psych meds, a study ...
Oracle has expanded its move into pharmaceutical innovation by investing an undisclosed “minor” sum in Proteus Digital Health, a company that has developed ingestible and wearable sensors. Proteus’ ...
Proteus Digital Health gained FDA de novo clearance for a new ingestible sensor designed to be combined with a drug, capping a four-year process of working with regulators to find the best approval ...
Digital medicine company Proteus Digital Health has raised an additional $52 million from undisclosed investors following a whopping $120 million raise the company announced just last month. That ...